Login / Signup

MDM2 for the practicing pathologist: a primer.

Aswathy Ashok MenonVikram DeshpandeDavid Suster
Published in: Journal of clinical pathology (2023)
The mouse double minute 2 ( MDM2 ) gene is located on the long arm of chromosome 12 and is the primary negative regulator of p53. The MDM2 gene encodes an E3 ubiquitin-protein ligase that mediates the ubiquitination of p53, leading to its degradation. MDM2 enhances tumour formation by inactivating the p53 tumour suppressor protein. The MDM2 gene also has many p53-independent functions. Alterations of MDM2 may occur through various mechanisms and contribute to the pathogenesis of many human tumours and some non-neoplastic diseases. Detection of MDM2 amplification is used in the clinical practice setting to help diagnose multiple tumour types, including lipomatous neoplasms, low-grade osteosarcomas and intimal sarcoma, among others. It is generally a marker of adverse prognosis, and MDM2-targeted therapies are currently in clinical trials. This article provides a concise overview of the MDM2 gene and discusses practical diagnostic applications pertaining to human tumour biology.
Keyphrases
  • low grade
  • copy number
  • clinical trial
  • endothelial cells
  • genome wide
  • clinical practice
  • randomized controlled trial
  • genome wide identification
  • label free
  • real time pcr